Publicacións en colaboración con investigadores/as de French Institute of Health and Medical Research (17)

2020

  1. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

    Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1462-1475

  2. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates

    Science advances, Vol. 6, Núm. 20, pp. eaaz9165

2015

  1. MiR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo

    Human Molecular Genetics, Vol. 24, Núm. 23, pp. 6721-6735

  2. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms

    Scientific Reports, Vol. 5

2013

  1. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice

    Diabetes, Vol. 62, Núm. 5, pp. 1681-1688

  2. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model

    Aging Cell, Vol. 12, Núm. 1, pp. 11-23

  3. Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation

    Cell Death and Differentiation, Vol. 20, Núm. 11, pp. 1546-1557

2012

  1. Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S

    Journal of Alzheimer's Disease, Vol. 31, Núm. 4, pp. 741-749

  2. Targeting phospho-Ser422 by active Tau immunotherapy in the THY-Tau22 mouse model: A suitable therapeutic approach

    Current Alzheimer Research, Vol. 9, Núm. 4, pp. 397-405

  3. Tau phosphorylation and sevoflurane anesthesia: An association to postoperative cognitive impairment

    Anesthesiology, Vol. 116, Núm. 4, pp. 779-787

2011

  1. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of muscleblind-like-1 isoforms

    Journal of Biological Chemistry, Vol. 286, Núm. 18, pp. 16435-16446

  2. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology

    Neurobiology of Disease, Vol. 43, Núm. 2, pp. 486-494

  3. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 16, pp. 6632-6637

2010

  1. From tau phosphorylation to tau aggregation: What about neuronal death?

    Biochemical Society Transactions, Vol. 38, Núm. 4, pp. 967-972

2009

  1. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication

    Journal of Neurochemistry, Vol. 110, Núm. 4, pp. 1321-1329

2007

  1. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism

    Brain, Vol. 130, Núm. 1, pp. 265-275

1995

  1. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys

    Brain Research, Vol. 691, Núm. 1-2, pp. 115-124